4//SEC Filing
Price David 4
Accession 0000899243-18-021374
CIK 0001314102other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:06 PM ET
Size
5.6 KB
Accession
0000899243-18-021374
Insider Transaction Report
Form 4
Price David
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-08-01+385,000→ 385,000 totalExercise: $2.22Exp: 2028-08-01→ Common Stock (385,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable in three equal annual installments beginning August 1, 2019.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001449336
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:06 PM ET
- Size
- 5.6 KB